热门资讯> 正文
Shuttle Pharmaceuticals收购分子
2025-11-22 01:14
- Shuttle Pharmaceuticals (NASDAQ:SHPH) announced on Friday that it has closed the acquisition of Molecule.
- Under the agreement, a subsidiary of the company acquired all of Molecule's assets and liabilities for a total purchase price of $8M and an additional contingent $2M payable in a combination of cash and shares of the company's common stock on the achievement of certain defined performance milestones.
- An initial $3 million was paid to Molecule at the closing of the transaction.
More on Shuttle Pharmaceuticals
- Shuttle to enter AI pharmaceutical market
- Seeking Alpha’s Quant Rating on Shuttle Pharmaceuticals
- Financial information for Shuttle Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
